Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome

被引:119
|
作者
Elstner, K
Selai, CE
Trimble, MR
Robertson, MM
机构
[1] Natl Hosp Neurol & Neurosurg, Inst Neurol, MSC Clin Neurosci & Honorary Res, London WC1N 3BG, England
[2] Royal Cornwall Hosp, Truro, Cornwall, England
[3] Inst Neurol, Raymond Way Neuropsychiat Unit, London WC1N 3BG, England
[4] UCL, Sch Med, London W1N 8AA, England
关键词
Gilles de la Tourette's Syndrome; health status; quality of life; psychopathology;
D O I
10.1034/j.1600-0447.2001.00147.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This is the first study to investigate the Quality of Life (QOL) of patients with Gilles de la Tourette's Syndrome (GTS). Method: One hundred and three out-patients with GTS completed a semi-structured interview and 90 of these completed questionnaires screening for depression, anxiety and obsessive-compulsive behaviour. QOL was measured with the SF-36 and the Quality of Life Assessment Schedule (QOLAS). Results: Patients with GTS showed significantly worse QOL than a general population sample. They had better QOL than patients with intractable epilepsy as measured by the QOLAS, although the SF-36 showed significant differences on the subscales Role Limitation due to physical problems and Social Functioning only. Factors influencing QOL domains were employment status, tic severity, obsessive-compulsive behaviour, anxiety and depression. Conclusion: QOL is impaired in patients with GTS. Measurement of QOL could be used alongside conventional measurements to assess benefit of treatment. We recommend the QOLAS and SF-36 be used.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 50 条
  • [41] Dystonic tics in patients with Gilles de la Tourette syndrome
    Szejko, Natalia
    Jakubczyk, Andrzej
    Dunalska, Anna
    Janik, Piotr
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2019, 53 (05) : 335 - 340
  • [42] Immunoglobulin treatment of Gilles de la Tourette's syndrome
    Muller, N
    Riedel, M
    Erfurth, A
    Moller, HJ
    NERVENARZT, 1997, 68 (11): : 914 - &
  • [43] Slips of the tongue in patients with Gilles de la Tourette syndrome
    Robert, Carina
    Weiblen, Ronja
    Wagner-Altendorf, Tobias A.
    Paulus, Theresa
    Mueller-Vahl, Kirsten
    Muenchau, Alexander
    Kraemer, Ulrike M.
    Heldmann, Marcus
    Roessner, Veit
    Muente, Thomas F.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2024, 6 (01):
  • [44] WHAT PREDICTS LONG-TERM QUALITY OF LIFE IN YOUNG PATIENTS WITH GILLES DE LA TOURETTE SYNDROME?
    Cavanna, A. E.
    David, K.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (10):
  • [45] KLAZOMANIA IN GILLES DE LA TOURETTE SYNDROME
    Kaczynska, J.
    Janik, P.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 69 - 69
  • [46] GILLES-DE-LA-TOURETTE SYNDROME
    SUCHOWERSKY, O
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 21 (01) : 48 - 52
  • [47] Nicotine and Gilles de la Tourette syndrome
    Erdmann, R
    Schneider, U
    PSYCHIATRISCHE PRAXIS, 1996, 23 (01) : 41 - 42
  • [48] HALOPERIDOL FOR GILLES DE LA TOURETTE SYNDROME
    BIXBY, EW
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (04): : 663 - &
  • [49] Tic Gilles de la Tourette syndrome
    Conrad, B
    KLINISCHE NEUROPHYSIOLOGIE, 1999, 30 (02) : 90 - 95
  • [50] Health-related quality of life in Gilles de la Tourette syndrome: A decade of research
    Cavanna, Andrea Eugenio
    David, Kate
    Bandera, Valentina
    Termine, Cristiano
    Balottin, Umberto
    Schrag, Anette
    Selai, Caroline
    BEHAVIOURAL NEUROLOGY, 2013, 27 (01) : 83 - 93